table of content
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tissue Biopsies
1.2.3 Liquid Biopsies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biopsy Market Perspective (2017-2028)
2.2 Cancer Biopsy Growth Trends by Region
2.2.1 Cancer Biopsy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Biopsy Historic Market Size by Region (2017-2022)
2.2.3 Cancer Biopsy Forecasted Market Size by Region (2023-2028)
2.3 Cancer Biopsy Market Dynamics
2.3.1 Cancer Biopsy Industry Trends
2.3.2 Cancer Biopsy Market Drivers
2.3.3 Cancer Biopsy Market Challenges
2.3.4 Cancer Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biopsy Players by Revenue
3.1.1 Global Top Cancer Biopsy Players by Revenue (2017-2022)
3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Biopsy Revenue
3.4 Global Cancer Biopsy Market Concentration Ratio
3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2021
3.5 Cancer Biopsy Key Players Head office and Area Served
3.6 Key Players Cancer Biopsy Product Solution and Service
3.7 Date of Enter into Cancer Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biopsy Breakdown Data by Type
4.1 Global Cancer Biopsy Historic Market Size by Type (2017-2022)
4.2 Global Cancer Biopsy Forecasted Market Size by Type (2023-2028)
5 Cancer Biopsy Breakdown Data by Application
5.1 Global Cancer Biopsy Historic Market Size by Application (2017-2022)
5.2 Global Cancer Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Biopsy Market Size (2017-2028)
6.2 North America Cancer Biopsy Market Size by Type
6.2.1 North America Cancer Biopsy Market Size by Type (2017-2022)
6.2.2 North America Cancer Biopsy Market Size by Type (2023-2028)
6.2.3 North America Cancer Biopsy Market Share by Type (2017-2028)
6.3 North America Cancer Biopsy Market Size by Application
6.3.1 North America Cancer Biopsy Market Size by Application (2017-2022)
6.3.2 North America Cancer Biopsy Market Size by Application (2023-2028)
6.3.3 North America Cancer Biopsy Market Share by Application (2017-2028)
6.4 North America Cancer Biopsy Market Size by Country
6.4.1 North America Cancer Biopsy Market Size by Country (2017-2022)
6.4.2 North America Cancer Biopsy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Biopsy Market Size (2017-2028)
7.2 Europe Cancer Biopsy Market Size by Type
7.2.1 Europe Cancer Biopsy Market Size by Type (2017-2022)
7.2.2 Europe Cancer Biopsy Market Size by Type (2023-2028)
7.2.3 Europe Cancer Biopsy Market Share by Type (2017-2028)
7.3 Europe Cancer Biopsy Market Size by Application
7.3.1 Europe Cancer Biopsy Market Size by Application (2017-2022)
7.3.2 Europe Cancer Biopsy Market Size by Application (2023-2028)
7.3.3 Europe Cancer Biopsy Market Share by Application (2017-2028)
7.4 Europe Cancer Biopsy Market Size by Country
7.4.1 Europe Cancer Biopsy Market Size by Country (2017-2022)
7.4.2 Europe Cancer Biopsy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biopsy Market Size (2017-2028)
8.2 Asia-Pacific Cancer Biopsy Market Size by Type
8.2.1 Asia-Pacific Cancer Biopsy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Biopsy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Biopsy Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Biopsy Market Size by Application
8.3.1 Asia-Pacific Cancer Biopsy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Biopsy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Biopsy Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Biopsy Market Size by Region
8.4.1 Asia-Pacific Cancer Biopsy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Biopsy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Biopsy Market Size (2017-2028)
9.2 Latin America Cancer Biopsy Market Size by Type
9.2.1 Latin America Cancer Biopsy Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Biopsy Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Biopsy Market Share by Type (2017-2028)
9.3 Latin America Cancer Biopsy Market Size by Application
9.3.1 Latin America Cancer Biopsy Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Biopsy Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Biopsy Market Share by Application (2017-2028)
9.4 Latin America Cancer Biopsy Market Size by Country
9.4.1 Latin America Cancer Biopsy Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Biopsy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biopsy Market Size (2017-2028)
10.2 Middle East & Africa Cancer Biopsy Market Size by Type
10.2.1 Middle East & Africa Cancer Biopsy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Biopsy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Biopsy Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Biopsy Market Size by Application
10.3.1 Middle East & Africa Cancer Biopsy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Biopsy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Biopsy Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Biopsy Market Size by Country
10.4.1 Middle East & Africa Cancer Biopsy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Biopsy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Biopsy Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2017-2022)
11.1.5 Qiagen N.V. Recent Developments
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Details
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Cancer Biopsy Introduction
11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.2.5 Illumina, Inc. Recent Developments
11.3 ANGLE Plc
11.3.1 ANGLE Plc Company Details
11.3.2 ANGLE Plc Business Overview
11.3.3 ANGLE Plc Cancer Biopsy Introduction
11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2017-2022)
11.3.5 ANGLE Plc Recent Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Cancer Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2017-2022)
11.4.5 Myriad Genetics Recent Developments
11.5 Hologic, Inc.
11.5.1 Hologic, Inc. Company Details
11.5.2 Hologic, Inc. Business Overview
11.5.3 Hologic, Inc. Cancer Biopsy Introduction
11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.5.5 Hologic, Inc. Recent Developments
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Details
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Cancer Biopsy Introduction
11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.6.5 Biocept, Inc. Recent Developments
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Details
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.7.5 Thermo Fisher Scientific, Inc. Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Cancer Biopsy Introduction
11.8.4 Danaher Revenue in Cancer Biopsy Business (2017-2022)
11.8.5 Danaher Recent Developments
11.9 Lucence Diagnostics Pte. Ltd.
11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2017-2022)
11.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments
11.10 GRAIL, Inc.
11.10.1 GRAIL, Inc. Company Details
11.10.2 GRAIL, Inc. Business Overview
11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.10.5 GRAIL, Inc. Recent Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Cancer Biopsy Introduction
11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2017-2022)
11.11.5 Guardant Health Recent Developments
11.12 Exact Sciences Corporation
11.12.1 Exact Sciences Corporation Company Details
11.12.2 Exact Sciences Corporation Business Overview
11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2017-2022)
11.12.5 Exact Sciences Corporation Recent Developments
11.13 Freenome Holdings, Inc.
11.13.1 Freenome Holdings, Inc. Company Details
11.13.2 Freenome Holdings, Inc. Business Overview
11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.13.5 Freenome Holdings, Inc. Recent Developments
11.14 Oncimmune
11.14.1 Oncimmune Company Details
11.14.2 Oncimmune Business Overview
11.14.3 Oncimmune Cancer Biopsy Introduction
11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2017-2022)
11.14.5 Oncimmune Recent Developments
11.15 Chronix Biomedical, Inc.
11.15.1 Chronix Biomedical, Inc. Company Details
11.15.2 Chronix Biomedical, Inc. Business Overview
11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.15.5 Chronix Biomedical, Inc. Recent Developments
11.16 Personal Genome Diagnostics Inc.
11.16.1 Personal Genome Diagnostics Inc. Company Details
11.16.2 Personal Genome Diagnostics Inc. Business Overview
11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2017-2022)
11.16.5 Personal Genome Diagnostics Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
